Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor (GABAA receptor) containing alpha1, alpha2, alpha3, or alpha5 and gamma2 subunits (GABAA receptor (alpha1/2/3/5, gamma2))

Target
GABAA receptor (alpha1/2/3/5, gamma2)
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor family, Receptor
01

Overview

The Gamma-aminobutyric acid type A (GABAA) receptor is a heteropentameric ligand-gated chloride channel that serves as the primary mediator of rapid inhibitory neurotransmission in the mammalian central nervous system [1: Sigel & Steinmann, 2012, J Biol Chem]. Receptors composed of alpha1, alpha2, alpha3, or alpha5 subunits alongside a gamma2 subunit are of particular clinical importance because they form the high-affinity binding site for benzodiazepines at the alpha/gamma2 subunit interface [2: Rudolph & Knoflach, 2011, Nat Rev Drug Discov]. The alpha1-containing receptors are widely expressed and primarily mediate sedative, amnestic, and anticonvulsant activities, whereas alpha2 and alpha3 subtypes are localized in the limbic system and spinal cord, mediating anxiolytic and muscle-relaxant effects [3: Möhler, 2006, J Recept Signal Transduct Res]. The alpha5-containing receptors are predominantly found in the hippocampus and are involved in learning and memory processes [4: Sieghart & Savic, 2018, Pharmacol Rev]. These receptor subtypes are key therapeutic targets for treating anxiety, insomnia, and epilepsy, though non-selective modulation is often limited by side effects such as ataxia and the potential for dependence [5: Atack, 2003, Curr Drug Targets CNS Neurol Disord]. Pharmacological research continues to focus on developing subtype-selective ligands to isolate desired therapeutic effects from adverse reactions.

Other names
Benzodiazepine-sensitive GABAA receptorGABA(A) receptor alpha-1/2/3/5 gamma-2 complexBZD-sensitive GABA receptorIonotropic GABA receptor
02

Mechanism of action

Positive allosteric modulation at the benzodiazepine binding site, which is located at the interface between the alpha (1, 2, 3, or 5) and gamma2 subunits; this modulation increases the frequency of chloride channel opening in response to GABA binding, thereby enhancing inhibitory neurotransmission [1: Sigel & Steinmann, 2012, J Biol Chem].

03

Biological functions

Inhibitory neurotransmissionChloride ion transportNeuronal hyperpolarizationRegulation of synaptic excitabilityMaintenance of sleep-wake cycles
04

Disease associations

Anxiety disordersInsomniaEpilepsyMuscle spasmsAlcohol withdrawal syndromePanic disorder
05

Safety considerations

SedationAtaxia and increased fall riskCognitive and memory impairmentTolerance and physical dependenceWithdrawal syndromeRespiratory depression in combination with other depressants
06

Interacting drugs

Diazepam

9 more in the full profile.

07

Biomarkers

Electroencephalography (EEG) beta-band power [6: Christian et al., 2015, J Psychopharmacol][11C]flumazenil Positron Emission Tomography (PET) receptor occupancy [7: Lingford-Hughes et al., 2002, J Cereb Blood Flow Metab]Saccadic eye movement velocity (SEV) [8: de Visser et al., 2003, J Psychopharmacol]

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor (GABAA receptor) containing alpha1, alpha2, alpha3, or alpha5 and gamma2 subunits (GABAA receptor (alpha1/2/3/5, gamma2)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor (GABAA receptor) containing alpha1, alpha2, alpha3, or alpha5 and gamma2 subunits (GABAA receptor (alpha1/2/3/5, gamma2)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call